Tosello‐Trampont et al. have reported that in a mouse model of NASH, TRAIL expression decreases, IFN‐γ production increases, and cytotoxicity is unaltered during NASH progression in liver NK cells.51 The gene discussed is IFNG; the disease is metabolic dysfunction-associated steatohepatitis.